FK
Fred Knoll Portfolio
Invests via Kno LLCapital Management LLC | Managed by Fred Knoll
Invests via Kno LLCapital Management LLC
Managed by Fred Knoll
Automatically Tracked
Fred Knoll Profile
With a robust background in real estate development, Fred Knoll is a seasoned operating executive known for spearheading transformative projects across diverse markets. His extensive experience encompasses overseeing complex acquisitions and leading teams through strategic initiatives that enhance property value. In his career, he has successfully navigated the intricacies of urban redevelopment, positioning him as a pivotal figure within the sector. As he continues to drive growth opportunities, Knoll's leadership fosters innovation and responsiveness to market demands. His profound understanding of industry dynamics underlines his relevance in shaping investment trends and influencing operational excellence.
With a robust background in real estate development, Fred Knoll is a seasoned operating executive known for spearheading transformative projects across diverse markets. His extensive experience encompasses overseeing complex acquisitions and leading teams through strategic initiatives that enhance property value. In his career, he has successfully navigated the intricacies of urban redevelopment, positioning him as a pivotal figure within the sector. As he continues to drive growth opportunities, Knoll's leadership fosters innovation and responsiveness to market demands. His profound understanding of industry dynamics underlines his relevance in shaping investment trends and influencing operational excellence.
Investment Philosophy & Strategy
Growth potential in real estate hinges on adaptability and vision, qualities that Fred Knoll exemplifies through his strategic leadership. Leveraging a wealth of operational expertise, he identifies and capitalizes on redevelopment opportunities to maximize asset performance. His focus extends beyond traditional acquisition practices; it encompasses fostering sustainable value creation while enhancing urban environments. Knoll's acute awareness of market nuances allows him to align investments with emerging trends effectively, ensuring a proactive approach in an ever-evolving landscape. As the sector shifts towards innovation-driven solutions, his entrepreneurial mindset positions him as a forward-thinking architect of change within the industry.
Growth potential in real estate hinges on adaptability and vision, qualities that Fred Knoll exemplifies through his strategic leadership. Leveraging a wealth of operational expertise, he identifies and capitalizes on redevelopment opportunities to maximize asset performance. His focus extends beyond traditional acquisition practices; it encompasses fostering sustainable value creation while enhancing urban environments. Knoll's acute awareness of market nuances allows him to align investments with emerging trends effectively, ensuring a proactive approach in an ever-evolving landscape. As the sector shifts towards innovation-driven solutions, his entrepreneurial mindset positions him as a forward-thinking architect of change within the industry.
Disclaimer: This Portfolio is derived from and computed based on publicly available data from SEC filings.
Gain and growth charts are calculated per selected timeframe:
188.09%
Gain +0.02%
Monthly
0.29%
Yearly
3.5%
Drawdown
79.7%
$104.57B
Equity
Holdings
$104.57B
Investment
$199.52B
$18.17B
Profit +$1.13M
Realized
$113.11B
Unrealized
-$94.95B
Dividends
$11.04M
Goals
Avg. 0% completed goals
Today
Compared To Yesterday
Gain
0.02%
Profit
$1.13M
Win %
45%
This Week
Compared To Last Week
Gain
-0.02%
Profit
-$16.27M
Win %
45%
This Month
Compared to last month
Gain
-0.02%
Profit
-$22.37M
Win %
45%
This Year
Compared to last year
Gain
-23.69%
Profit
$45.09M
Win %
44%
GRS
GRS
+152,501.3%
+$1.21B 
ORGS Orgenesis Inc.
+87,400%
+$17,697.8 CFS
CFS
+75,936.5%
+$459.42M HYTM
HYTM
+13,210.26%
+$208.31M GG
GG
+144.2%
+$3.72B SYNM
SYNM
+41.92%
+$69.51M ACEL
ACEL
+22.81%
+$865.09M IOTN
IOTN
+17.67%
+$557.04M 
NEWP New Pacific Metals Corp.
+6.85%
+$194,000 
MGTX MeiraGTx Holdings plc
+5.1%
+$600,000 
ABVX Abivax SA ADR
+5%
+$154,000 
CDE Coeur Mining, Inc.
+2.87%
+$68,762.16 
NUVB Nuvation Bio Inc.
+1.5%
+$111,901.37 
ABEO Abeona Therapeutics Inc.
0%
$0 
ACTG Acacia Research Corporation
0%
$0 
AEM Agnico Eagle Mines Limited
0%
$0 
AGI Alamos Gold Inc.
0%
$0 
ALDX Aldeyra Therapeutics Inc.
0%
$0 
ALT Altimmune, Inc.
0%
$0 
BAH Booz Allen Hamilton Holding Corporation
0%
$0 
BHVN Biohaven Ltd.
0%
$0 
CGAU Centerra Gold Inc.
0%
$0 
CREAF Creative Technology Ltd.
0%
$0 
DC Dakota Gold Corp
0%
$0 
ELTX Elicio Therapeutics Inc.
0%
$0 
ENTX Entera Bio Ltd.
0%
$0 
FORD Forward Industries Inc.
0%
$0 
FNV Franco-Nevada Corporation
0%
$0 
GERN Geron Corporation
0%
$0 
GROY Gold Royalty Corp
0%
$0 
HL Hecla Mining Company
0%
$0 
KGC Kinross Gold Corporation
0%
$0 
NOC Northrop Grumman Corporation
0%
$0 
OCUL Ocular Therapeutix Inc.
0%
$0 
OR OR ROYALTIES INC COMMON STOCK
0%
$0 
PAAS Pan American Silver Corp.
0%
$0 
PM Philip Morris International Inc.
0%
$0 
RGLD Royal Gold Inc.
0%
$0 
SA Seabridge Gold Inc.
0%
$0 
SSRM Ssr Mining Inc.
0%
$0 
TFPM Triple Flag Precious Metals Corp
0%
$0 
WPM Wheaton Precious Metals Corp.
0%
$0 
ITA iShares U.S. Aerospace & Defense ETF
0%
$0 
PHYS Sprott Physical Gold Trust
0%
$0 
PKD Parker Drilling Co
0%
$0 
PSLV Sprott Physical Silver Trust
0%
$0 
AMRZ Amrize Ltd.
0%
$0 PHS
PHS
0%
$0 HLTH
HLTH
0%
$0 NEXM
NEXM
0%
$0 BVF
BVF
0%
$0 TLCV
TLCVF
0%
$0 BIOV
BIOV
0%
$0 TAG
TAG
0%
$0 DMX
DMX
0%
$0 ELE
ELE
0%
$0 
VMET Versamet Royalties Corporation
0%
$0 ZICA
ZICA
0%
$0 MIIS
MIIS
0%
$0 POCC
POCC
0%
$0 0320
032087108
-95.88%
-$313.56B DPTR
DPTR
-79.29%
-$1.13B FLML
FLML
-78.35%
-$21.95B ATPA
ATPAQ
-75%
-$23.52B DSCO
DSCO
-33.51%
-$1.52B APPX
APPX
-30.93%
-$19.16B ALTI
ALTI
-13.48%
-$28.38M 
PHAR Pharming Group N.V. - ADR
-0.1%
-$40.91 Events
Loading...
Dividends
Dividend Analysis
Loading...
No Data
| Trades 724 | Longs Won 283/724 39% | Profit Factor 1.03 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $11.85B |
| Average Win $2.18B | Best Trade (Dec 31) $72.84B | Sharpe Ratio -5.03 |
| Average Loss -$1.36B | Worst Trade (Sep 29) -$282.03B | Z-Score -8.53 (100%) |
| Commissions $0 | Avg. Trade Length 3y 4m 3w | Expectancy $25.09M |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | 92.21% | 94.49% | 95.85% | 96.82% | 97.59% | 98.22% | 98.75% | 99.22% | 99.63% |
| Consecutive Losing Trades | 77 | 69 | 62 | 54 | 46 | 39 | 31 | 23 | 15 | 8 |
Hover over the desired column for a detailed explanation.
Returns
Overall, Monthly| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
| 0320 032087108 | 343,100 | $45.01B | $13.48B | - | -$31.53B | -70.04% | -95.877% |
| ABEO Abeona Therapeutics Inc. | 485,515 | $2.39M | $2.12M | - | -$270,367.16 | -11.33% | 0.0 |
| ABVX Abivax SA ADR | 35,000 | $4.66M | $3.23M | - | -$1.43M | -30.68% | +5.001% |
| ACEL ACEL | 2.22M | $3.92B | $4.66B | - | $740.05M | 18.89% | +22.807% |
| ACTG Acacia Research Corporation | 274,300 | $1.3M | $1.18M | - | -$120,692 | -9.28% | 0.0 |
| AEM Agnico Eagle Mines Limited | 52,750 | $2.54M | $9.34M | - | $6.79M | 267.15% | 0.0 |
| AGI Alamos Gold Inc. | 50,000 | $701,930 | $1.53M | - | $828,570 | 118.04% | 0.0 |
| ALDX Aldeyra Therapeutics Inc. | 5.48M | $30.78M | $4.33M | - | -$26.45M | -85.95% | 0.0 |
| ALT Altimmune, Inc. | 160,000 | $1.06M | $369,600 | - | -$694,400 | -65.26% | 0.0 |
| ALTI ALTI | 59,127 | $210.49M | $182.11M | - | -$28.38M | -13.48% | -13.483% |
| AMRZ Amrize Ltd. | 9,175 | $513,983.5 | $332,960.75 | - | -$181,022.75 | -35.22% | 0.0 |
| APPX APPX | 1.5M | $51.93B | $42.78B | - | -$9.14B | -17.61% | -30.933% |
| ATPA ATPAQ | 1.34M | $31.36B | $7.84B | - | -$23.52B | -75% | -74.998% |
| BAH Booz Allen Hamilton Holding Corporation | 13,000 | $1.05M | $934,310 | - | -$112,580 | -10.75% | 0.0 |
| BHVN Biohaven Ltd. | 2.33M | $17.98B | $25.45M | - | -$17.95B | -99.86% | 0.0 |
| BIOV BIOV | 975,300 | $12.96B | $12.96B | - | - | - | 0.0 |
| BVF BVF | 100,000 | $1.65M | $1.65M | - | - | - | 0.0 |
| CDE Coeur Mining, Inc. | 159,912 | $3.04M | $2.46M | - | -$574,270.48 | -18.9% | +2.87% |
| CFS CFS | 220,100 | $25.45M | $460.02M | - | $434.57M | 1,707.39% | +75,936.5% |
| CGAU Centerra Gold Inc. | 359,000 | $2.59M | $7.56M | - | $4.98M | 192.23% | 0.0 |
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
FAQ
Which stocks have generated the highest profits for Fred Knoll?
The largest contributions to the portfolio's profits come from the following stocks: BIOV - $149.08B, MDVN - $125.48B, SLPHQ - $60.89B, HOOK - $60.47B, and APPX - $51.56B. These positions have been the main drivers of growth and have significantly impacted the investor's overall performance.
Which stocks have generated the largest losses for this investor?
The largest losses in the portfolio are associated with the following stocks: 032087108 - $282.03B, Applied Therapeutics Inc - $25.92B, FMD - $24.28B, DPTR - $13B, and HYTM - $12.59B. These positions have had the most negative impact on overall performance and highlight the weaker areas of the portfolio.
What dividends does Fred Knoll's portfolio generate?
The portfolio generates substantial dividend income, with a total of $11.04M earned over time. The largest contributors to dividend income include Precision Drilling Corporation - $6.44M, Blackstone Inc - $578,650, Altria Group, Inc - $454,286, Hecla Mining Company - $403,108.3, and Acacia Research Corporation - $377,162.5. This indicates that dividends play a meaningful role in the investor's overall strategy.
How stable are Fred Knoll's monthly returns?
Fred Knoll's monthly returns look highly volatile. The portfolio shows large month-to-month swings, and the broader risk profile suggests that performance can change sharply over short periods. This kind of pattern may suit users who are comfortable with significant fluctuations, but it is less likely to appeal to those who prefer steadier and more predictable results.
Can Fred Knoll's strategy be considered aggressive or moderate?
Fred Knoll's strategy can be considered aggressive. The combination of high drawdowns, elevated volatility, and/or concentrated positions suggests a willingness to accept significant risk in pursuit of higher long-term returns. This approach is generally more suitable for users who are comfortable with large fluctuations in portfolio value.
Should beginners follow Fred Knoll's strategy?
Fred Knoll's strategy is unlikely to be suitable for beginners. The portfolio shows signs of high risk, significant volatility, or structural complexity, which can make it difficult to follow and potentially stressful for less experienced users. This type of approach is generally better suited to more advanced investors.
2026 © Marketlog. All Rights Reserved.
